nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2B6—Thiotepa—urinary bladder cancer	0.29	0.501	CbGbCtD
Perhexiline—CYP3A4—Thiotepa—urinary bladder cancer	0.0891	0.154	CbGbCtD
Perhexiline—CYP2B6—Cisplatin—urinary bladder cancer	0.08	0.138	CbGbCtD
Perhexiline—CYP2B6—Doxorubicin—urinary bladder cancer	0.0536	0.0926	CbGbCtD
Perhexiline—CYP2D6—Doxorubicin—urinary bladder cancer	0.0259	0.0447	CbGbCtD
Perhexiline—CYP3A4—Etoposide—urinary bladder cancer	0.0241	0.0417	CbGbCtD
Perhexiline—CYP3A4—Doxorubicin—urinary bladder cancer	0.0165	0.0284	CbGbCtD
Perhexiline—CPT1A—prostate gland—urinary bladder cancer	0.0127	0.108	CbGeAlD
Perhexiline—CPT2—prostate gland—urinary bladder cancer	0.0121	0.102	CbGeAlD
Perhexiline—CPT2—seminal vesicle—urinary bladder cancer	0.0102	0.0866	CbGeAlD
Perhexiline—Unsteadiness—Fluorouracil—urinary bladder cancer	0.00868	0.0593	CcSEcCtD
Perhexiline—CPT1A—renal system—urinary bladder cancer	0.00867	0.0735	CbGeAlD
Perhexiline—CPT2—renal system—urinary bladder cancer	0.00823	0.0697	CbGeAlD
Perhexiline—CPT2—urethra—urinary bladder cancer	0.00808	0.0685	CbGeAlD
Perhexiline—CPT1A—female reproductive system—urinary bladder cancer	0.00694	0.0589	CbGeAlD
Perhexiline—CYP3A4—urine—urinary bladder cancer	0.00661	0.056	CbGeAlD
Perhexiline—CPT2—female reproductive system—urinary bladder cancer	0.00659	0.0559	CbGeAlD
Perhexiline—CYP2D6—urine—urinary bladder cancer	0.0065	0.0551	CbGeAlD
Perhexiline—CPT1A—vagina—urinary bladder cancer	0.00628	0.0532	CbGeAlD
Perhexiline—CPT2—vagina—urinary bladder cancer	0.00596	0.0505	CbGeAlD
Perhexiline—Papilloedema—Cisplatin—urinary bladder cancer	0.00519	0.0355	CcSEcCtD
Perhexiline—CPT1A—lymph node—urinary bladder cancer	0.00406	0.0344	CbGeAlD
Perhexiline—CPT2—lymph node—urinary bladder cancer	0.00385	0.0327	CbGeAlD
Perhexiline—Balance disorder—Fluorouracil—urinary bladder cancer	0.00318	0.0218	CcSEcCtD
Perhexiline—Cachexia—Epirubicin—urinary bladder cancer	0.00297	0.0203	CcSEcCtD
Perhexiline—Extrapyramidal disorder—Thiotepa—urinary bladder cancer	0.0028	0.0191	CcSEcCtD
Perhexiline—Cachexia—Doxorubicin—urinary bladder cancer	0.00274	0.0188	CcSEcCtD
Perhexiline—Optic neuritis—Cisplatin—urinary bladder cancer	0.00268	0.0183	CcSEcCtD
Perhexiline—Polyneuropathy—Epirubicin—urinary bladder cancer	0.0026	0.0178	CcSEcCtD
Perhexiline—Optic neuritis—Etoposide—urinary bladder cancer	0.00246	0.0168	CcSEcCtD
Perhexiline—Polyneuropathy—Doxorubicin—urinary bladder cancer	0.00241	0.0165	CcSEcCtD
Perhexiline—CYP2B6—renal system—urinary bladder cancer	0.00214	0.0182	CbGeAlD
Perhexiline—Liver injury—Cisplatin—urinary bladder cancer	0.00196	0.0134	CcSEcCtD
Perhexiline—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00177	0.0121	CcSEcCtD
Perhexiline—CYP2B6—female reproductive system—urinary bladder cancer	0.00171	0.0145	CbGeAlD
Perhexiline—Abdominal pain—Valrubicin—urinary bladder cancer	0.00171	0.0117	CcSEcCtD
Perhexiline—Hepatocellular injury—Cisplatin—urinary bladder cancer	0.00165	0.0113	CcSEcCtD
Perhexiline—Syncope—Mitomycin—urinary bladder cancer	0.00164	0.0112	CcSEcCtD
Perhexiline—CYP3A4—renal system—urinary bladder cancer	0.00162	0.0137	CbGeAlD
Perhexiline—Loss of consciousness—Mitomycin—urinary bladder cancer	0.00161	0.011	CcSEcCtD
Perhexiline—CYP2D6—renal system—urinary bladder cancer	0.00159	0.0135	CbGeAlD
Perhexiline—Asthenia—Valrubicin—urinary bladder cancer	0.00156	0.0106	CcSEcCtD
Perhexiline—CYP2B6—vagina—urinary bladder cancer	0.00155	0.0131	CbGeAlD
Perhexiline—Shock—Mitomycin—urinary bladder cancer	0.00147	0.01	CcSEcCtD
Perhexiline—Ataxia—Thiotepa—urinary bladder cancer	0.00144	0.00982	CcSEcCtD
Perhexiline—Dizziness—Valrubicin—urinary bladder cancer	0.00143	0.0098	CcSEcCtD
Perhexiline—Anorexia—Mitomycin—urinary bladder cancer	0.00142	0.00973	CcSEcCtD
Perhexiline—Vomiting—Valrubicin—urinary bladder cancer	0.00138	0.00942	CcSEcCtD
Perhexiline—Optic neuritis—Epirubicin—urinary bladder cancer	0.00138	0.00942	CcSEcCtD
Perhexiline—Rash—Valrubicin—urinary bladder cancer	0.00137	0.00935	CcSEcCtD
Perhexiline—Dermatitis—Valrubicin—urinary bladder cancer	0.00137	0.00934	CcSEcCtD
Perhexiline—Headache—Valrubicin—urinary bladder cancer	0.00136	0.00929	CcSEcCtD
Perhexiline—Decreased appetite—Mitomycin—urinary bladder cancer	0.0013	0.00888	CcSEcCtD
Perhexiline—CYP3A4—female reproductive system—urinary bladder cancer	0.00129	0.011	CbGeAlD
Perhexiline—Nausea—Valrubicin—urinary bladder cancer	0.00129	0.0088	CcSEcCtD
Perhexiline—Fatigue—Mitomycin—urinary bladder cancer	0.00129	0.0088	CcSEcCtD
Perhexiline—Optic neuritis—Doxorubicin—urinary bladder cancer	0.00127	0.00872	CcSEcCtD
Perhexiline—CYP2D6—female reproductive system—urinary bladder cancer	0.00127	0.0108	CbGeAlD
Perhexiline—Ataxia—Fluorouracil—urinary bladder cancer	0.00119	0.00813	CcSEcCtD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	0.00117	0.0075	CbGpPWpGaD
Perhexiline—CPT1A—PPARA activates gene expression—NCOR1—urinary bladder cancer	0.00116	0.00741	CbGpPWpGaD
Perhexiline—CPT2—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.00115	0.00736	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.00114	0.00726	CbGpPWpGaD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—urinary bladder cancer	0.00114	0.00725	CbGpPWpGaD
Perhexiline—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.00113	0.00722	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.00113	0.00721	CbGpPWpGaD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.00113	0.0072	CbGpPWpGaD
Perhexiline—Muscular weakness—Fluorouracil—urinary bladder cancer	0.00111	0.00762	CcSEcCtD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.0011	0.00702	CbGpPWpGaD
Perhexiline—CYP2B6—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.0011	0.007	CbGpPWpGaD
Perhexiline—Asthenia—Mitomycin—urinary bladder cancer	0.00107	0.00733	CcSEcCtD
Perhexiline—Liver injury—Epirubicin—urinary bladder cancer	0.00101	0.00689	CcSEcCtD
Perhexiline—Dizziness—Mitomycin—urinary bladder cancer	0.000987	0.00675	CcSEcCtD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000972	0.0062	CbGpPWpGaD
Perhexiline—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.000971	0.00664	CcSEcCtD
Perhexiline—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.000955	0.00653	CcSEcCtD
Perhexiline—Sweating—Gemcitabine—urinary bladder cancer	0.00095	0.00649	CcSEcCtD
Perhexiline—Vomiting—Mitomycin—urinary bladder cancer	0.000949	0.00649	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000949	0.00605	CbGpPWpGaD
Perhexiline—CPT1A—Circadian Clock—EP300—urinary bladder cancer	0.000948	0.00605	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000944	0.00602	CbGpPWpGaD
Perhexiline—Rash—Mitomycin—urinary bladder cancer	0.000942	0.00644	CcSEcCtD
Perhexiline—Dermatitis—Mitomycin—urinary bladder cancer	0.000941	0.00643	CcSEcCtD
Perhexiline—Headache—Mitomycin—urinary bladder cancer	0.000936	0.0064	CcSEcCtD
Perhexiline—Liver injury—Doxorubicin—urinary bladder cancer	0.000932	0.00637	CcSEcCtD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000931	0.00594	CbGpPWpGaD
Perhexiline—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.000905	0.00619	CcSEcCtD
Perhexiline—Tension—Thiotepa—urinary bladder cancer	0.000903	0.00617	CcSEcCtD
Perhexiline—Nervousness—Thiotepa—urinary bladder cancer	0.000894	0.00611	CcSEcCtD
Perhexiline—Nausea—Mitomycin—urinary bladder cancer	0.000887	0.00607	CcSEcCtD
Perhexiline—Gait disturbance—Epirubicin—urinary bladder cancer	0.000868	0.00594	CcSEcCtD
Perhexiline—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.000848	0.0058	CcSEcCtD
Perhexiline—CPT1A—PPARA activates gene expression—PPARG—urinary bladder cancer	0.000832	0.00531	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—CDKN1A—urinary bladder cancer	0.000831	0.0053	CbGpPWpGaD
Perhexiline—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.000829	0.00567	CcSEcCtD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	0.000814	0.0052	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	0.000809	0.00517	CbGpPWpGaD
Perhexiline—Gait disturbance—Doxorubicin—urinary bladder cancer	0.000803	0.00549	CcSEcCtD
Perhexiline—CPT1A—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.000799	0.0051	CbGpPWpGaD
Perhexiline—Convulsion—Thiotepa—urinary bladder cancer	0.000797	0.00545	CcSEcCtD
Perhexiline—CPT2—PPARA activates gene expression—EP300—urinary bladder cancer	0.000785	0.00501	CbGpPWpGaD
Perhexiline—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.000784	0.00536	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.000783	0.005	CbGpPWpGaD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.000782	0.00499	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTZ1—urinary bladder cancer	0.000781	0.00498	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.000777	0.00496	CbGpPWpGaD
Perhexiline—Flushing—Cisplatin—urinary bladder cancer	0.000769	0.00526	CcSEcCtD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000768	0.0049	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000765	0.00488	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000749	0.00478	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTO2—urinary bladder cancer	0.00074	0.00472	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—NAT1—urinary bladder cancer	0.00074	0.00472	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000739	0.00471	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000728	0.00465	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000725	0.00463	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000717	0.00457	CbGpPWpGaD
Perhexiline—Anorexia—Thiotepa—urinary bladder cancer	0.000716	0.00489	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—GSTO2—urinary bladder cancer	0.00071	0.00453	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—NAT1—urinary bladder cancer	0.00071	0.00453	CbGpPWpGaD
Perhexiline—Flushing—Etoposide—urinary bladder cancer	0.000705	0.00482	CcSEcCtD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.0007	0.00447	CbGpPWpGaD
Perhexiline—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000693	0.00442	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—UGT2B7—urinary bladder cancer	0.000677	0.00432	CbGpPWpGaD
Perhexiline—Tremor—Cisplatin—urinary bladder cancer	0.000676	0.00462	CcSEcCtD
Perhexiline—Paraesthesia—Thiotepa—urinary bladder cancer	0.000674	0.00461	CcSEcCtD
Perhexiline—Convulsion—Fluorouracil—urinary bladder cancer	0.000659	0.00451	CcSEcCtD
Perhexiline—Decreased appetite—Thiotepa—urinary bladder cancer	0.000653	0.00446	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000649	0.00414	CbGpPWpGaD
Perhexiline—Fatigue—Thiotepa—urinary bladder cancer	0.000647	0.00443	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—FAS—urinary bladder cancer	0.000642	0.0041	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00064	0.00409	CbGpPWpGaD
Perhexiline—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.00063	0.00431	CcSEcCtD
Perhexiline—Convulsion—Cisplatin—urinary bladder cancer	0.000625	0.00427	CcSEcCtD
Perhexiline—Ataxia—Methotrexate—urinary bladder cancer	0.000618	0.00423	CcSEcCtD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000617	0.00394	CbGpPWpGaD
Perhexiline—Diplopia—Epirubicin—urinary bladder cancer	0.000615	0.00421	CcSEcCtD
Perhexiline—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000614	0.0042	CcSEcCtD
Perhexiline—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000611	0.00418	CcSEcCtD
Perhexiline—CPT2—Metabolism—CYP4B1—urinary bladder cancer	0.000609	0.00389	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000609	0.00389	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000604	0.00386	CbGpPWpGaD
Perhexiline—Anorexia—Gemcitabine—urinary bladder cancer	0.000602	0.00412	CcSEcCtD
Perhexiline—Urticaria—Thiotepa—urinary bladder cancer	0.000597	0.00408	CcSEcCtD
Perhexiline—Abdominal pain—Thiotepa—urinary bladder cancer	0.000594	0.00406	CcSEcCtD
Perhexiline—Anorexia—Fluorouracil—urinary bladder cancer	0.000592	0.00405	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000585	0.00373	CbGpPWpGaD
Perhexiline—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.000583	0.00399	CcSEcCtD
Perhexiline—Loss of consciousness—Etoposide—urinary bladder cancer	0.000581	0.00397	CcSEcCtD
Perhexiline—Ataxia—Epirubicin—urinary bladder cancer	0.000579	0.00396	CcSEcCtD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000577	0.00368	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—SLC19A1—urinary bladder cancer	0.000576	0.00367	CbGpPWpGaD
Perhexiline—Convulsion—Etoposide—urinary bladder cancer	0.000573	0.00392	CcSEcCtD
Perhexiline—Insomnia—Gemcitabine—urinary bladder cancer	0.000571	0.00391	CcSEcCtD
Perhexiline—Diplopia—Doxorubicin—urinary bladder cancer	0.000569	0.00389	CcSEcCtD
Perhexiline—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000569	0.00389	CcSEcCtD
Perhexiline—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000567	0.00388	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—TP53—urinary bladder cancer	0.000566	0.00361	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000565	0.00361	CbGpPWpGaD
Perhexiline—Insomnia—Fluorouracil—urinary bladder cancer	0.000562	0.00384	CcSEcCtD
Perhexiline—Anorexia—Cisplatin—urinary bladder cancer	0.000561	0.00384	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	0.000561	0.00358	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PRSS3—urinary bladder cancer	0.000561	0.00358	CbGpPWpGaD
Perhexiline—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000558	0.00381	CcSEcCtD
Perhexiline—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000549	0.00376	CcSEcCtD
Perhexiline—Fatigue—Gemcitabine—urinary bladder cancer	0.000545	0.00372	CcSEcCtD
Perhexiline—CPT1A—PPARA activates gene expression—EP300—urinary bladder cancer	0.000544	0.00347	CbGpPWpGaD
Perhexiline—Muscular weakness—Epirubicin—urinary bladder cancer	0.000543	0.00371	CcSEcCtD
Perhexiline—CPT1A—Metabolism—GSTZ1—urinary bladder cancer	0.000541	0.00345	CbGpPWpGaD
Perhexiline—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00054	0.00369	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.000539	0.00344	CbGpPWpGaD
Perhexiline—Asthenia—Thiotepa—urinary bladder cancer	0.000539	0.00368	CcSEcCtD
Perhexiline—Ataxia—Doxorubicin—urinary bladder cancer	0.000535	0.00366	CcSEcCtD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000533	0.0034	CbGpPWpGaD
Perhexiline—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000531	0.00339	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	0.00053	0.00338	CbGpPWpGaD
Perhexiline—Paraesthesia—Cisplatin—urinary bladder cancer	0.000529	0.00362	CcSEcCtD
Perhexiline—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000521	0.00357	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—GSTZ1—urinary bladder cancer	0.00052	0.00332	CbGpPWpGaD
Perhexiline—Anorexia—Etoposide—urinary bladder cancer	0.000514	0.00352	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000514	0.00328	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000513	0.00328	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—NAT1—urinary bladder cancer	0.000513	0.00327	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTO2—urinary bladder cancer	0.000513	0.00327	CbGpPWpGaD
Perhexiline—Decreased appetite—Cisplatin—urinary bladder cancer	0.000512	0.0035	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000505	0.00322	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000504	0.00321	CbGpPWpGaD
Perhexiline—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000502	0.00343	CcSEcCtD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.0005	0.00319	CbGpPWpGaD
Perhexiline—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000498	0.00318	CbGpPWpGaD
Perhexiline—Dizziness—Thiotepa—urinary bladder cancer	0.000497	0.0034	CcSEcCtD
Perhexiline—Urticaria—Fluorouracil—urinary bladder cancer	0.000493	0.00337	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—GSTO2—urinary bladder cancer	0.000493	0.00315	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—NAT1—urinary bladder cancer	0.000493	0.00315	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000487	0.00311	CbGpPWpGaD
Perhexiline—Sweating—Methotrexate—urinary bladder cancer	0.000486	0.00332	CcSEcCtD
Perhexiline—Paraesthesia—Etoposide—urinary bladder cancer	0.000484	0.00331	CcSEcCtD
Perhexiline—Weight decreased—Epirubicin—urinary bladder cancer	0.000481	0.00329	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.00048	0.00306	CbGpPWpGaD
Perhexiline—Vomiting—Thiotepa—urinary bladder cancer	0.000477	0.00326	CcSEcCtD
Perhexiline—Rash—Thiotepa—urinary bladder cancer	0.000474	0.00324	CcSEcCtD
Perhexiline—Dermatitis—Thiotepa—urinary bladder cancer	0.000473	0.00323	CcSEcCtD
Perhexiline—Headache—Thiotepa—urinary bladder cancer	0.00047	0.00322	CcSEcCtD
Perhexiline—CPT1A—Metabolism—UGT2B7—urinary bladder cancer	0.000469	0.00299	CbGpPWpGaD
Perhexiline—Decreased appetite—Etoposide—urinary bladder cancer	0.000469	0.00321	CcSEcCtD
Perhexiline—Fatigue—Etoposide—urinary bladder cancer	0.000465	0.00318	CcSEcCtD
Perhexiline—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000465	0.00318	CcSEcCtD
Perhexiline—Hepatitis—Methotrexate—urinary bladder cancer	0.000455	0.00311	CcSEcCtD
Perhexiline—Sweating—Epirubicin—urinary bladder cancer	0.000455	0.00311	CcSEcCtD
Perhexiline—Asthenia—Gemcitabine—urinary bladder cancer	0.000453	0.0031	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000451	0.00288	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00045	0.00287	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—TYMP—urinary bladder cancer	0.000448	0.00286	CbGpPWpGaD
Perhexiline—Nausea—Thiotepa—urinary bladder cancer	0.000446	0.00305	CcSEcCtD
Perhexiline—Weight decreased—Doxorubicin—urinary bladder cancer	0.000445	0.00304	CcSEcCtD
Perhexiline—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000445	0.00284	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000441	0.00302	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000431	0.00275	CbGpPWpGaD
Perhexiline—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00043	0.00294	CcSEcCtD
Perhexiline—Urticaria—Etoposide—urinary bladder cancer	0.000429	0.00293	CcSEcCtD
Perhexiline—Abdominal pain—Etoposide—urinary bladder cancer	0.000426	0.00292	CcSEcCtD
Perhexiline—Hepatitis—Epirubicin—urinary bladder cancer	0.000426	0.00291	CcSEcCtD
Perhexiline—Asthenia—Cisplatin—urinary bladder cancer	0.000422	0.00289	CcSEcCtD
Perhexiline—CPT1A—Metabolism—CYP4B1—urinary bladder cancer	0.000422	0.0027	CbGpPWpGaD
Perhexiline—Sweating—Doxorubicin—urinary bladder cancer	0.000421	0.00288	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000412	0.00263	CbGpPWpGaD
Perhexiline—Dizziness—Fluorouracil—urinary bladder cancer	0.000411	0.00281	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000406	0.00259	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—NAT2—urinary bladder cancer	0.000406	0.00259	CbGpPWpGaD
Perhexiline—Vomiting—Gemcitabine—urinary bladder cancer	0.000402	0.00275	CcSEcCtD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000401	0.00256	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC19A1—urinary bladder cancer	0.000399	0.00255	CbGpPWpGaD
Perhexiline—Rash—Gemcitabine—urinary bladder cancer	0.000398	0.00272	CcSEcCtD
Perhexiline—Dermatitis—Gemcitabine—urinary bladder cancer	0.000398	0.00272	CcSEcCtD
Perhexiline—Headache—Gemcitabine—urinary bladder cancer	0.000396	0.00271	CcSEcCtD
Perhexiline—Flushing—Epirubicin—urinary bladder cancer	0.000395	0.0027	CcSEcCtD
Perhexiline—Vomiting—Fluorouracil—urinary bladder cancer	0.000395	0.0027	CcSEcCtD
Perhexiline—Hepatitis—Doxorubicin—urinary bladder cancer	0.000394	0.00269	CcSEcCtD
Perhexiline—Rash—Fluorouracil—urinary bladder cancer	0.000392	0.00268	CcSEcCtD
Perhexiline—Dermatitis—Fluorouracil—urinary bladder cancer	0.000391	0.00268	CcSEcCtD
Perhexiline—Headache—Fluorouracil—urinary bladder cancer	0.000389	0.00266	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—NAT2—urinary bladder cancer	0.000389	0.00248	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PRSS3—urinary bladder cancer	0.000389	0.00248	CbGpPWpGaD
Perhexiline—Asthenia—Etoposide—urinary bladder cancer	0.000387	0.00265	CcSEcCtD
Perhexiline—CYP2B6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000384	0.00245	CbGpPWpGaD
Perhexiline—Nausea—Gemcitabine—urinary bladder cancer	0.000375	0.00257	CcSEcCtD
Perhexiline—Vomiting—Cisplatin—urinary bladder cancer	0.000374	0.00256	CcSEcCtD
Perhexiline—Rash—Cisplatin—urinary bladder cancer	0.000371	0.00254	CcSEcCtD
Perhexiline—Dermatitis—Cisplatin—urinary bladder cancer	0.000371	0.00254	CcSEcCtD
Perhexiline—Nausea—Fluorouracil—urinary bladder cancer	0.000369	0.00252	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	0.000367	0.00234	CbGpPWpGaD
Perhexiline—Flushing—Doxorubicin—urinary bladder cancer	0.000365	0.0025	CcSEcCtD
Perhexiline—Tension—Epirubicin—urinary bladder cancer	0.000364	0.00249	CcSEcCtD
Perhexiline—Nervousness—Epirubicin—urinary bladder cancer	0.00036	0.00246	CcSEcCtD
Perhexiline—Dizziness—Etoposide—urinary bladder cancer	0.000357	0.00244	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—PTEN—urinary bladder cancer	0.000352	0.00225	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—RRM2—urinary bladder cancer	0.00035	0.00223	CbGpPWpGaD
Perhexiline—Nausea—Cisplatin—urinary bladder cancer	0.00035	0.00239	CcSEcCtD
Perhexiline—Convulsion—Methotrexate—urinary bladder cancer	0.000343	0.00235	CcSEcCtD
Perhexiline—Vomiting—Etoposide—urinary bladder cancer	0.000343	0.00235	CcSEcCtD
Perhexiline—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.00034	0.00217	CbGpPWpGaD
Perhexiline—Rash—Etoposide—urinary bladder cancer	0.00034	0.00233	CcSEcCtD
Perhexiline—Dermatitis—Etoposide—urinary bladder cancer	0.00034	0.00232	CcSEcCtD
Perhexiline—Headache—Etoposide—urinary bladder cancer	0.000338	0.00231	CcSEcCtD
Perhexiline—Tension—Doxorubicin—urinary bladder cancer	0.000336	0.0023	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—EP300—urinary bladder cancer	0.000336	0.00214	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000336	0.00214	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000334	0.00213	CbGpPWpGaD
Perhexiline—Nervousness—Doxorubicin—urinary bladder cancer	0.000333	0.00228	CcSEcCtD
Perhexiline—Syncope—Epirubicin—urinary bladder cancer	0.000332	0.00227	CcSEcCtD
Perhexiline—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000326	0.00223	CcSEcCtD
Perhexiline—CPT2—Metabolism—HPGDS—urinary bladder cancer	0.000324	0.00207	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ENO2—urinary bladder cancer	0.000324	0.00207	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000323	0.00206	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000323	0.00206	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000322	0.00206	CbGpPWpGaD
Perhexiline—Convulsion—Epirubicin—urinary bladder cancer	0.000321	0.0022	CcSEcCtD
Perhexiline—Nausea—Etoposide—urinary bladder cancer	0.00032	0.00219	CcSEcCtD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000318	0.00203	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTT1—urinary bladder cancer	0.000314	0.00201	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000312	0.00214	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000312	0.00199	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—HPGDS—urinary bladder cancer	0.000311	0.00198	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—TYMP—urinary bladder cancer	0.000311	0.00198	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00031	0.00198	CbGpPWpGaD
Perhexiline—Anorexia—Methotrexate—urinary bladder cancer	0.000308	0.00211	CcSEcCtD
Perhexiline—Syncope—Doxorubicin—urinary bladder cancer	0.000307	0.0021	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—GSTT1—urinary bladder cancer	0.000302	0.00192	CbGpPWpGaD
Perhexiline—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000301	0.00206	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000299	0.00191	CbGpPWpGaD
Perhexiline—Shock—Epirubicin—urinary bladder cancer	0.000297	0.00203	CcSEcCtD
Perhexiline—Convulsion—Doxorubicin—urinary bladder cancer	0.000297	0.00203	CcSEcCtD
Perhexiline—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000295	0.00188	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000292	0.002	CcSEcCtD
Perhexiline—Insomnia—Methotrexate—urinary bladder cancer	0.000292	0.002	CcSEcCtD
Perhexiline—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000291	0.00186	CbGpPWpGaD
Perhexiline—Paraesthesia—Methotrexate—urinary bladder cancer	0.00029	0.00198	CcSEcCtD
Perhexiline—Anorexia—Epirubicin—urinary bladder cancer	0.000288	0.00197	CcSEcCtD
Perhexiline—CPT1A—Metabolism—NAT2—urinary bladder cancer	0.000281	0.00179	CbGpPWpGaD
Perhexiline—Decreased appetite—Methotrexate—urinary bladder cancer	0.000281	0.00192	CcSEcCtD
Perhexiline—Fatigue—Methotrexate—urinary bladder cancer	0.000279	0.0019	CcSEcCtD
Perhexiline—Shock—Doxorubicin—urinary bladder cancer	0.000275	0.00188	CcSEcCtD
Perhexiline—Insomnia—Epirubicin—urinary bladder cancer	0.000273	0.00187	CcSEcCtD
Perhexiline—Paraesthesia—Epirubicin—urinary bladder cancer	0.000272	0.00186	CcSEcCtD
Perhexiline—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00027	0.00185	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.00027	0.00173	CbGpPWpGaD
Perhexiline—Anorexia—Doxorubicin—urinary bladder cancer	0.000267	0.00182	CcSEcCtD
Perhexiline—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000267	0.0017	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000266	0.0017	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000264	0.00181	CcSEcCtD
Perhexiline—Decreased appetite—Epirubicin—urinary bladder cancer	0.000263	0.0018	CcSEcCtD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000262	0.00167	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—NQO1—urinary bladder cancer	0.000261	0.00167	CbGpPWpGaD
Perhexiline—Fatigue—Epirubicin—urinary bladder cancer	0.000261	0.00178	CcSEcCtD
Perhexiline—Urticaria—Methotrexate—urinary bladder cancer	0.000257	0.00176	CcSEcCtD
Perhexiline—Abdominal pain—Methotrexate—urinary bladder cancer	0.000255	0.00175	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000254	0.00162	CbGpPWpGaD
Perhexiline—Insomnia—Doxorubicin—urinary bladder cancer	0.000253	0.00173	CcSEcCtD
Perhexiline—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000251	0.00172	CcSEcCtD
Perhexiline—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000247	0.00169	CcSEcCtD
Perhexiline—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000243	0.00166	CcSEcCtD
Perhexiline—CPT1A—Metabolism—RRM2—urinary bladder cancer	0.000243	0.00155	CbGpPWpGaD
Perhexiline—Fatigue—Doxorubicin—urinary bladder cancer	0.000241	0.00165	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—urinary bladder cancer	0.00024	0.00153	CbGpPWpGaD
Perhexiline—Urticaria—Epirubicin—urinary bladder cancer	0.00024	0.00164	CcSEcCtD
Perhexiline—Abdominal pain—Epirubicin—urinary bladder cancer	0.000239	0.00163	CcSEcCtD
Perhexiline—Asthenia—Methotrexate—urinary bladder cancer	0.000232	0.00159	CcSEcCtD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000229	0.00146	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000229	0.00156	CcSEcCtD
Perhexiline—CPT1A—Metabolism—ENO2—urinary bladder cancer	0.000225	0.00143	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—HPGDS—urinary bladder cancer	0.000225	0.00143	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000223	0.00143	CbGpPWpGaD
Perhexiline—Urticaria—Doxorubicin—urinary bladder cancer	0.000222	0.00152	CcSEcCtD
Perhexiline—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000221	0.00151	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000221	0.00141	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTT1—urinary bladder cancer	0.000218	0.00139	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTP1—urinary bladder cancer	0.000218	0.00139	CbGpPWpGaD
Perhexiline—Asthenia—Epirubicin—urinary bladder cancer	0.000217	0.00148	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000216	0.00138	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000215	0.00137	CbGpPWpGaD
Perhexiline—Dizziness—Methotrexate—urinary bladder cancer	0.000214	0.00146	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000211	0.00135	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.00021	0.00134	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTP1—urinary bladder cancer	0.000209	0.00133	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000206	0.00132	CbGpPWpGaD
Perhexiline—Vomiting—Methotrexate—urinary bladder cancer	0.000205	0.0014	CcSEcCtD
Perhexiline—Rash—Methotrexate—urinary bladder cancer	0.000204	0.00139	CcSEcCtD
Perhexiline—Dermatitis—Methotrexate—urinary bladder cancer	0.000204	0.00139	CcSEcCtD
Perhexiline—CPT2—Metabolism—TYMS—urinary bladder cancer	0.000203	0.00129	CbGpPWpGaD
Perhexiline—Headache—Methotrexate—urinary bladder cancer	0.000202	0.00138	CcSEcCtD
Perhexiline—Asthenia—Doxorubicin—urinary bladder cancer	0.000201	0.00137	CcSEcCtD
Perhexiline—CPT2—Metabolism—NCOR1—urinary bladder cancer	0.0002	0.00128	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTM1—urinary bladder cancer	0.0002	0.00128	CbGpPWpGaD
Perhexiline—Dizziness—Epirubicin—urinary bladder cancer	0.0002	0.00137	CcSEcCtD
Perhexiline—Vomiting—Epirubicin—urinary bladder cancer	0.000192	0.00131	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—GSTM1—urinary bladder cancer	0.000192	0.00123	CbGpPWpGaD
Perhexiline—Nausea—Methotrexate—urinary bladder cancer	0.000192	0.00131	CcSEcCtD
Perhexiline—CPT2—Metabolism—GPX1—urinary bladder cancer	0.000192	0.00122	CbGpPWpGaD
Perhexiline—Rash—Epirubicin—urinary bladder cancer	0.000191	0.0013	CcSEcCtD
Perhexiline—Dermatitis—Epirubicin—urinary bladder cancer	0.00019	0.0013	CcSEcCtD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000189	0.00121	CbGpPWpGaD
Perhexiline—Headache—Epirubicin—urinary bladder cancer	0.000189	0.0013	CcSEcCtD
Perhexiline—CPT2—Metabolism—ERCC2—urinary bladder cancer	0.000188	0.0012	CbGpPWpGaD
Perhexiline—Dizziness—Doxorubicin—urinary bladder cancer	0.000185	0.00127	CcSEcCtD
Perhexiline—CPT1A—Metabolism—NQO1—urinary bladder cancer	0.000181	0.00116	CbGpPWpGaD
Perhexiline—Nausea—Epirubicin—urinary bladder cancer	0.00018	0.00123	CcSEcCtD
Perhexiline—Vomiting—Doxorubicin—urinary bladder cancer	0.000178	0.00122	CcSEcCtD
Perhexiline—CPT2—Metabolism—MTHFR—urinary bladder cancer	0.000177	0.00113	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000177	0.00113	CbGpPWpGaD
Perhexiline—Rash—Doxorubicin—urinary bladder cancer	0.000176	0.00121	CcSEcCtD
Perhexiline—Dermatitis—Doxorubicin—urinary bladder cancer	0.000176	0.00121	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000176	0.00112	CbGpPWpGaD
Perhexiline—Headache—Doxorubicin—urinary bladder cancer	0.000175	0.0012	CcSEcCtD
Perhexiline—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000174	0.00111	CbGpPWpGaD
Perhexiline—Nausea—Doxorubicin—urinary bladder cancer	0.000166	0.00114	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000153	0.000978	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTP1—urinary bladder cancer	0.000151	0.000964	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000146	0.000933	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000145	0.000927	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PPARG—urinary bladder cancer	0.000144	0.000916	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000143	0.000915	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000141	0.000902	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—TYMS—urinary bladder cancer	0.00014	0.000896	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—NCOR1—urinary bladder cancer	0.000139	0.000886	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTM1—urinary bladder cancer	0.000139	0.000886	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CREBBP—urinary bladder cancer	0.000138	0.00088	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000137	0.000875	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000134	0.000852	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GPX1—urinary bladder cancer	0.000133	0.000849	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000132	0.00084	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ERCC2—urinary bladder cancer	0.000131	0.000833	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	0.000128	0.000817	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—MTHFR—urinary bladder cancer	0.000123	0.000783	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	0.000121	0.000775	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NAT1—urinary bladder cancer	0.000121	0.000775	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGS2—urinary bladder cancer	0.000113	0.000721	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	0.000111	0.000709	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	0.0001	0.000638	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PPARG—urinary bladder cancer	9.95e-05	0.000635	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTEN—urinary bladder cancer	9.85e-05	0.000628	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CREBBP—urinary bladder cancer	9.56e-05	0.00061	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	9.5e-05	0.000606	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	9.44e-05	0.000603	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—EP300—urinary bladder cancer	9.39e-05	0.000599	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.37e-05	0.000598	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	9.2e-05	0.000587	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	8.9e-05	0.000568	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	8.73e-05	0.000557	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.61e-05	0.000549	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	8.44e-05	0.000539	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NAT1—urinary bladder cancer	8.44e-05	0.000539	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGS2—urinary bladder cancer	7.83e-05	0.0005	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	7.72e-05	0.000493	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TYMP—urinary bladder cancer	7.36e-05	0.000469	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	6.95e-05	0.000443	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTEN—urinary bladder cancer	6.83e-05	0.000436	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NAT2—urinary bladder cancer	6.65e-05	0.000425	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	6.56e-05	0.000419	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—EP300—urinary bladder cancer	6.51e-05	0.000415	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	6.39e-05	0.000408	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	5.82e-05	0.000371	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—RRM2—urinary bladder cancer	5.74e-05	0.000366	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.52e-05	0.000352	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.52e-05	0.000352	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	5.32e-05	0.000339	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ENO2—urinary bladder cancer	5.32e-05	0.000339	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	5.16e-05	0.000329	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TYMP—urinary bladder cancer	5.11e-05	0.000326	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.05e-05	0.000322	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NAT2—urinary bladder cancer	4.62e-05	0.000295	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.54e-05	0.00029	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.29e-05	0.000274	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NQO1—urinary bladder cancer	4.29e-05	0.000274	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.18e-05	0.000267	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.99e-05	0.000255	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.7e-05	0.000236	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.7e-05	0.000236	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.58e-05	0.000229	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	3.57e-05	0.000228	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.34e-05	0.000213	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TYMS—urinary bladder cancer	3.32e-05	0.000212	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	3.29e-05	0.00021	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	3.29e-05	0.00021	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GPX1—urinary bladder cancer	3.15e-05	0.000201	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	3.09e-05	0.000197	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.02e-05	0.000193	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.98e-05	0.00019	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	2.9e-05	0.000185	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.61e-05	0.000167	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.48e-05	0.000159	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.42e-05	0.000154	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.42e-05	0.000154	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PPARG—urinary bladder cancer	2.35e-05	0.00015	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.34e-05	0.00015	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.31e-05	0.000147	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.28e-05	0.000146	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.28e-05	0.000146	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	2.26e-05	0.000144	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.19e-05	0.00014	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.15e-05	0.000137	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.02e-05	0.000129	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.95e-05	0.000124	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.85e-05	0.000118	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.64e-05	0.000104	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.62e-05	0.000104	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.62e-05	0.000103	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.57e-05	0.0001	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.54e-05	9.83e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.51e-05	9.64e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.49e-05	9.53e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.49e-05	9.53e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.43e-05	9.12e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.4e-05	8.96e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.32e-05	8.42e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.29e-05	8.22e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.12e-05	7.16e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.07e-05	6.83e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.07e-05	6.83e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.03e-05	6.56e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	8.42e-06	5.37e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.34e-06	4.68e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—EP300—urinary bladder cancer	7e-06	4.47e-05	CbGpPWpGaD
